Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824873/ https://www.ncbi.nlm.nih.gov/pubmed/31695847 http://dx.doi.org/10.18632/oncotarget.27289 |
_version_ | 1783464820367949824 |
---|---|
author | Gravina, Giovanni Luca Mancini, Andrea Colapietro, Alessandro Marampon, Francesco Sferra, Roberta Pompili, Simona Biordi, Leda Assunta Iorio, Roberto Flati, Vincenzo Argueta, Christian Landesman, Yosef Kauffman, Michael Shacham, Sharon Festuccia, Claudio |
author_facet | Gravina, Giovanni Luca Mancini, Andrea Colapietro, Alessandro Marampon, Francesco Sferra, Roberta Pompili, Simona Biordi, Leda Assunta Iorio, Roberto Flati, Vincenzo Argueta, Christian Landesman, Yosef Kauffman, Michael Shacham, Sharon Festuccia, Claudio |
author_sort | Gravina, Giovanni Luca |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6824873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-68248732019-11-06 Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer Gravina, Giovanni Luca Mancini, Andrea Colapietro, Alessandro Marampon, Francesco Sferra, Roberta Pompili, Simona Biordi, Leda Assunta Iorio, Roberto Flati, Vincenzo Argueta, Christian Landesman, Yosef Kauffman, Michael Shacham, Sharon Festuccia, Claudio Oncotarget Correction Impact Journals LLC 2019-10-29 /pmc/articles/PMC6824873/ /pubmed/31695847 http://dx.doi.org/10.18632/oncotarget.27289 Text en Copyright: © 2019 Gravina et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Gravina, Giovanni Luca Mancini, Andrea Colapietro, Alessandro Marampon, Francesco Sferra, Roberta Pompili, Simona Biordi, Leda Assunta Iorio, Roberto Flati, Vincenzo Argueta, Christian Landesman, Yosef Kauffman, Michael Shacham, Sharon Festuccia, Claudio Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
title | Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
title_full | Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
title_fullStr | Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
title_full_unstemmed | Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
title_short | Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
title_sort | correction: pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824873/ https://www.ncbi.nlm.nih.gov/pubmed/31695847 http://dx.doi.org/10.18632/oncotarget.27289 |
work_keys_str_mv | AT gravinagiovanniluca correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT manciniandrea correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT colapietroalessandro correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT maramponfrancesco correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT sferraroberta correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT pompilisimona correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT biordiledaassunta correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT iorioroberto correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT flativincenzo correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT arguetachristian correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT landesmanyosef correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT kauffmanmichael correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT shachamsharon correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer AT festucciaclaudio correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer |